Manav Singla, MD
Allergy & Immunology · White Marsh, MDNPI 1801996079
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $127,666 of the $168,109 with a category attached, or 75.9%. 46 manufacturers reported payments, led by Sanofi at 41.5% of the total. Among allergy & immunology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 997 payments — averaging $168.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$70K
- GSK$44K
- Boehringer Ingelheim$13K
- Alk-abello, Inc$12K
- Regeneron Healthcare Solutions, Inc.$6K
- Teva Pharmaceuticals USA, Inc.$4K
- plus $20K from 40 others
Across 70 payments — averaging $4826.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$79K
- Teva Pharmaceuticals USA, Inc.$66K
- Astrazeneca UK Limited$65K
- Genentech, Inc.$34K
- Sanofi US Services Inc.$31K
- GSK$30K
- plus $32K from 2 others
What the payments were for
- Consulting fees$15,8619%
- Speaking & faculty fees$127,66676%
- Travel & lodging$3,5602%
- Food & beverage$20,77212%
- Education$2510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$87,355
- NUCALA$41,448
- Odactra$4,800
- AirDuo RespiClick$3,760
- ProAir Digihaler$3,760
- ArmonAir Digihaler$3,760
- XOLAIR$1,725
- AYVAKIT$782
- CUTAQUIG$180
- AirDuo Digihaler$125
- Andembry$116
- Rhapsido$108
- ORALAIR$107
- CINQAIR$102
How this compares
$168,109 in reported general payments places this provider in the 95th percentile of 105 allergy & immunology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HaegardaC1 Esterase Inhibitor | 12 | $250,340 |
| Dupixent SyringeDupilumab | 17 | $65,190 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $30,990 |
| Breo ElliptaFluticasone/Vilanterol | 32 | $22,075 |
| Spiriva RespimatTiotropium Bromide | 11 | $14,512 |
| Advair HfaFluticasone Propion/Salmeterol | 28 | $14,510 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $6,524 |
| Arnuity ElliptaFluticasone Furoate | 23 | $6,068 |
| Qvar RedihalerBeclomethasone Dipropionate | 14 | $5,735 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,380 |
| Epinephrine | 17 | $3,933 |
| Azelastine Hcl | 59 | $3,150 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 88 | $2,774 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $2,006 |
| BreynaBudesonide/Formoterol Fumarate | 13 | $1,840 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHaegarda | $816 | $250,34012 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta, Incruse Ellipta | $44,031 | $63,513104 claims |
| Boehringer IngelheimSpiriva Respimat | $12,566 | $14,51211 claims |
| AstraZenecaSymbicort | $1,892 | $6,52411 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $4,262 | $5,73514 claims |
| Hikma Pharmaceuticals USAEpinephrine | $16 | $3,93317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 105 allergy & immunology providers in Maryland.
Other allergy & immunology in White Marsh
- Antoine AzarBaltimore$612K
- Mark ScarupaWheaton$508K
- Sally BaileyBaltimore$344K
- Sudhir SekhsariaRockville$87K
- Nasim ReedyGaithersburg$63K
- Kristin SokolRockville$62K
- Rachel SchreiberRockville$48K
- Eric OliverBaltimore$31K
- Matthew MardineyBel Air$21K
- Melanie DispenzaBaltimore$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.